Prevention of follicular maturation in endometriosis by subcutaneous infusion of luteinizing hormone-releasing hormone agonist started in the luteal phase

Condition tags

MeSH descriptors

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (21)

• Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis. via openalex
• Potential new treatment of endometriosis: reversible inhibition of pituitary-ovarian function by chronic intranasal administration of a luteinizing hormone-releasing hormone (LH-RH) agonist via openalex
• Suppression of Follicular Maturation by Infusion of a Luteinizing Hormone-Releasing Hormone Agonist Starting during the Late Luteal Phase in the Stumptailed Macaque Monkey via openalex
• Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist. via openalex
• Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin) via openalex
• W2019569711 via openalex
• W2035862679 via openalex
• W2040233599 via openalex
• W2056489288 via openalex
• W2067682105 via openalex
• W2329442555 via openalex
• W2408619637 via openalex
• W2418323373 via openalex
• W2477008945 via openalex
• W6607058909 via openalex
• W140454929 via openalex
• W6642239427 via openalex
• W1978860276 via openalex
• W2014955036 via openalex
• W2015817028 via openalex
• W2019037346 via openalex

Cited by (15)

• Gonadotropin releasing hormone agonists: Expanding vistas 2011
• GnRH agonists and add‐back therapy: is there a perfect combination? 1998
• Cyclic and individualized administration of gonadotropin-releasing hormone agonists plus progestogens: An alternative protocol for contraception 1997
• Endocrine effects of GnRH analogue with low‐dose hormone replacement therapy in women with endometriosis 1995
• Estrogenic suppression by different administration schedules of goserelin depot for treatment of endometriosis 1993
• Gonadotrophin releasing hormone agonist suppressive treatment of ovarian function decreases serum LH‐<i>β</i> and bloactive LH but maintains elevated levels of LH‐<i>α</i> 1991
• Cholesterol fractions and apolipoproteins during endometriosis treatment by a gonadotrophin releasing hormone (GnRH) agonist implant or by danazol 1991
• Efficacy and Endocrine Effects of Medical Treatment of Endometriosis 1991
• Basic and clinical aspects of GnRH‐agonists in reproduction 1990
• Gonadotrophin releasing hormone agonist (buserelin) in the treatment of endometriosis: changes in the extent of the disease and in CA 125 serum levels after 6‐month therapy 1990
• Long-term suppression of ovarian function by a luteinizing-hormone releasing hormone agonist implant in patients with endometriosis 1990
• Buserelin 1990
• Serum Concentration and Urinary Excretion of the Luteinizing Hormone-Releasing Hormone Agonist Buserelin in Patients with Endometriosis 1989
• GnRH Analogues in the Treatment of Endometriosis 1989
• Escape from the down-regulation of the pituitary-ovarian axis following decreased infusion of luteinizing hormone-releasing hormone agonist 1988

Source provenance

europepmc

last seen: 2026-06-04T01:30:01.192114+00:00

openalex

last seen: 2026-06-10T17:14:06.276822+00:00

pubmed

last seen: 2026-05-13T22:09:25.758913+00:00

unpaywall

last seen: 2026-06-04T02:00:05.705006+00:00